Deals
Canadian Drug Maker Apotex Hires Banks to Prepare for IPO
- Company was sold to SK Capital in deal announced two years ago
- Founder Barry Sherman and his wife were murdered in 2017
This article is for subscribers only.
Canadian generic drug manufacturer Apotex Inc. is making plans for a potential initial public offering next year, according to people familiar with the matter.
RBC Capital Markets, Jefferies Financial Group and TD Securities are advisers for the deal, the people said, asking not to be identified discussing information that is still private. No decisions have been made yet on exact timing or size, and more banks may be added to the lineup later, they said.